These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Van den Bergh PYK; van Doorn PA; Hadden RDM; Avau B; Vankrunkelsven P; Allen JA; Attarian S; Blomkwist-Markens PH; Cornblath DR; Eftimov F; Goedee HS; Harbo T; Kuwabara S; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Sommer C; Topaloglu HA Eur J Neurol; 2021 Nov; 28(11):3556-3583. PubMed ID: 34327760 [TBL] [Abstract][Full Text] [Related]
23. Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs. Darbà J; Marsà A Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):665-670. PubMed ID: 34720023 [TBL] [Abstract][Full Text] [Related]
24. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Joint Task Force of the EFNS and the PNS J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283 [TBL] [Abstract][Full Text] [Related]
26. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526 [TBL] [Abstract][Full Text] [Related]
27. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)]. Iijima M; Koike H; Sobue G Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094 [TBL] [Abstract][Full Text] [Related]
28. Progress in Hematopoietic Stem Cell Transplantation for CIDP. Qin Z; Huang Q; Zou J; Tang L; Hu Z; Tang X Int J Med Sci; 2020; 17(2):234-241. PubMed ID: 32038107 [TBL] [Abstract][Full Text] [Related]
29. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies. Reynolds J; Sachs G; Stavros K R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997 [TBL] [Abstract][Full Text] [Related]
30. A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy. Allen JA; Butler L; Levine T; Haudrich A Adv Ther; 2021 Jan; 38(1):316-328. PubMed ID: 33113101 [TBL] [Abstract][Full Text] [Related]
32. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis. Broers MC; Bunschoten C; Nieboer D; Lingsma HF; Jacobs BC Neuroepidemiology; 2019; 52(3-4):161-172. PubMed ID: 30669140 [TBL] [Abstract][Full Text] [Related]
33. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature. Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859 [TBL] [Abstract][Full Text] [Related]
34. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany. Mengel D; Fraune L; Sommer N; Stettner M; Reese JP; Dams J; Glynn RJ; Balzer-Geldsetzer M; Dodel R; Tackenberg B Muscle Nerve; 2018 Nov; 58(5):681-687. PubMed ID: 30073683 [TBL] [Abstract][Full Text] [Related]
35. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy]. Radziwill AJ; Kuntzer T; Steck AJ Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589 [TBL] [Abstract][Full Text] [Related]
36. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. Nobile-Orazio E J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201 [TBL] [Abstract][Full Text] [Related]
37. Monocentric study of 28 cases of chronic inflammatory demyelinating polyneuropathy: first Tunisian study. Mansour M; Rachdi A; Baradai N; Kacem A; Bedoui I; Mrissa R Neurol Sci; 2022 Jan; 43(1):565-571. PubMed ID: 33945035 [TBL] [Abstract][Full Text] [Related]
39. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision. Joint Task Force of the EFNS and the PNS J Peripher Nerv Syst; 2010 Mar; 15(1):1-9. PubMed ID: 20433600 [TBL] [Abstract][Full Text] [Related]
40. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Van den Bergh PY; Hadden RD; Bouche P; Cornblath DR; Hahn A; Illa I; Koski CL; Léger JM; Nobile-Orazio E; Pollard J; Sommer C; van Doorn PA; van Schaik IN; ; Eur J Neurol; 2010 Mar; 17(3):356-63. PubMed ID: 20456730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]